Dianthus Therapeutics | Der Umsatz

Aktienkurs
52.43
Täglich Wechseln
0.56 1.08%
Monatlich
4.21%
Jährlich
149.07%
Q1 Prognose
48.02




Der Umsatz Veränderung Datum
Akebia Therapeutics USD 57.34M 10.84M 2025-03
Alaunos Therapeutics USD 2K 2K 2025-03
Avita Medical AUD 18.42M 14K 2025-06
Celltrion KRW 1.33T 300B 2026-03
Cspc Pharmaceutical CNY 6.62B 358.95M 2025-09
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 396K 203K 2025-09
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 9.53M 1.99M 2025-06
Moderna USD 678M 342M 2025-12
Neuren Pharmaceuticals AUD 14.14M 179.96M 2025-06
Organigram Holdings CAD 80.06M 9.27M 2025-09
Organon & Co USD 1.51B 90M 2025-12
Pharma Mar EUR 35.7M 20.69M 2025-09
Qiagen NV USD 457.38M 6.06M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Sartorius EUR 927.6M 84.4M 2025-12
Sino Biopharmaceutical CNY 17.57B 4.58B 2025-06
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Viatris USD 3.76B 190M 2025-09
Xeris Pharmaceuticals USD 74.38M 2.84M 2025-09
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09


Dianthus Therapeutics Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.